Growth Factors · 2017 · 54 citations · 32 references
Life SciencesImmunologyOncologyCancer ImmunologyInnate ImmunityMolecular OncologyCytokines In Tumor ImmunityNatural Killer Cell BiologyNatural Killer Cell FunctionNatural Killer Cell RegulationHepatocellular Carcinoma PathogenesisInhibitory Killer Cell Immunoglobulin-like ReceptorsMicrorna Function In CancerMicrorna In CancerMicrorna Regulation In CancerNatural Killer Cell CytotoxicityNatural Killer Cell Receptor Nkg2dNkg2d-mediated Recognition
miR-615-5p was characterized by our group as a tumour suppressor. IGF-1 R activates a downstream signalling pathway, well characterized in liver cells, however, its role in immunity especially Natural Killer cells (NKs) remains vague. This study aimed at investigating the regulatory role of miR-615-5p on IGF signalling and its impact on NKs cytotoxicity in HCC. Our results showed an upregulation in miR-615-5p and IGF-1 R in NKs of 130 HCC patients compared to 35 controls. Forcing the expression of miR-615-5p, repressed IGF-IR, attenuated NKs cytotoxicity, decreased CD56dim, increased CD56bright NK subsets and reduced the cytotoxic markers NKG2D, TNF-α and perforins. It repressed NKG2D ligand (ULBP2) in Huh-7 cells. In conclusion, miR-615-5p represses IGF-1 R in NKs and their target hepatocytes; however, it has a contradicting impact on HCC progression on both cell types. These findings might pave the way for better understanding the role of microRNAs in NKs function and HCC immune-pathogenesis.
32
Comparative studies of human FcRIII-positive and negative natural killer cells.
Arnon Nagler, Lewis L. Lanier, Steven E. Cwirla et al. · The Journal of Immunology · 1989 · 683 citations · Full text
The insulin-like growth factor I receptor: a key to tumor growth?
Renato Baserga · PubMed · 1995 · 549 citations